Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (211-220 of 361) with videos related to

Pageof 37
Sort By:
JMIR Research Protocols|August 25, 2025
An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized TrialKimberley T Lee, Briana McLeod, Brian Egleston, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
British Journal of Cancer|April 20, 2016
Adjuvant ovarian function suppression and cognitive function in women with breast cancerKelly-Anne Phillips, Meredith M Regan, Karin Ribi, et al.
JAMA Oncology|July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A ReviewHeather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2022
Impact of integrating genomic data into the electronic health record on genetics care deliveryKelsey S Lau-Min, Danielle McKenna, Stephanie Byers Asher, et al.
Carcinogenesis|March 12, 2013
Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markersYonglan Zheng, Temidayo O Ogundiran, Adeyinka G Falusi, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.
Nature Communications|July 16, 2025
Comprehensive RAD51C ovarian cancer variant analysis uncouples homologous recombination and replicative functionsHayley L Rein, Yashpal Rawal, Anna L Palovcak-Lightbourn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2021
EUS-based Pancreatic Cancer Surveillance in <i>BRCA1/BRCA2/PALB2/ATM</i> Carriers Without a Family History of Pancreatic CancerBryson W Katona, Jessica M Long, Nuzhat A Ahmad, et al.
Pageof 37

Showing results (211-220 of 361) with videos related to

Sort By:
Pageof 37
JMIR Research Protocols|August 25, 2025
An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized TrialKimberley T Lee, Briana McLeod, Brian Egleston, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
British Journal of Cancer|April 20, 2016
Adjuvant ovarian function suppression and cognitive function in women with breast cancerKelly-Anne Phillips, Meredith M Regan, Karin Ribi, et al.
JAMA Oncology|July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A ReviewHeather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 15, 2022
Impact of integrating genomic data into the electronic health record on genetics care deliveryKelsey S Lau-Min, Danielle McKenna, Stephanie Byers Asher, et al.
Carcinogenesis|March 12, 2013
Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markersYonglan Zheng, Temidayo O Ogundiran, Adeyinka G Falusi, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.
Nature Communications|July 16, 2025
Comprehensive RAD51C ovarian cancer variant analysis uncouples homologous recombination and replicative functionsHayley L Rein, Yashpal Rawal, Anna L Palovcak-Lightbourn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 3, 2021
EUS-based Pancreatic Cancer Surveillance in <i>BRCA1/BRCA2/PALB2/ATM</i> Carriers Without a Family History of Pancreatic CancerBryson W Katona, Jessica M Long, Nuzhat A Ahmad, et al.
Pageof 37